Pilot Trial Tests Patient Navigation Plus mHealth for Dual Opioid-Methamphetamine Users Starting Buprenorphine — Addressing Critical Care Transition Gap

References

1. 1.University of Washington. (2023). Patient Navigator Plus Remote mHealth Adherence Support With Incentives to Improve Linkage and Retention Among Hospitalized Patients With Opioid and Methamphetamine Use Who Initiate Buprenorphine. ClinicalTrials.gov. NCT06027814. https://clinicaltrials.gov/study/NCT06027814
2. 2.Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018). Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug and Alcohol Dependence, 193, 14-20. https://doi.org/10.1016/j.drugalcdep.2018.04.003
3. 3.Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020). Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Network Open, 3(2), e1920622. https://doi.org/10.1001/jamanetworkopen.2019.20622
4. 4.Hedegaard, H., Miniño, A. M., & Warner, M. (2020). Drug overdose deaths in the United States, 1999–2018. NCHS Data Brief, 394, 1-8. https://doi.org/10.15620/cdc:100687
5. 5.Bharat, C., Hickman, M., Barbieri, S., Degenhardt, L., Larney, S., Kimber, J., Copeland, J., & Farrell, M. (2018). Big data and predictive modelling for the opioid crisis: existing research and future potential. The Lancet Digital Health, 1(2), e102-e105. https://doi.org/10.1016/S2589-7500(18)30017-2